Literature DB >> 27815746

Volume, specialty background, practice pattern, and outcomes in endoscopic retrograde cholangiopancreatography: an analysis of the national inpatient sample.

Jac Cooper1, Sapan Desai1, Steve Scaife2, Chad Gonczy3, John Mellinger4.   

Abstract

BACKGROUND: Endoscopic retrograde cholangiopancreatography (ERCP) is a complex endoscopic procedure performed by both gastroenterologists and surgeons. There has been recent controversy regarding training paradigms for gastrointestinal endoscopy. No prior studies have evaluated comparative outcomes for ERCP in relation to specialty training background. This study utilized the National Inpatient Sample (NIS) to assess ERCP outcomes as a function of training background, practice pattern, and individual provider volume.
METHODS: NIS data was queried from 2007 to 2009. Gastroenterologists and surgeons were identified by procedural profiles and unique physician identifiers. Comorbidity was assessed via Charlson Score. Outcomes including cost, length of stay (LOS), and mortality were analyzed, with and without propensity score matching (PSM). Analysis of outcomes as a function of provider procedural volume was also performed. Comparison for statistical significance was accomplished via t test.
RESULTS: A total of 110,811 ERCP's were identified, of which 42,025 (37.9%) were performed by surgeons. Surgeons exhibited longer LOS (8.7 vs. 7.2 days), overall cost ($24,739 vs. $16,960), and mortality (3.9 vs. 1.2%, odds ratio 3.3), with p < 0.001 for all measures. 71.6% of surgical patients, versus 19.6% of gastroenterologic, underwent subsequent inpatient laparoscopic cholecystectomy or laparotomy. Outcome differences persisted when PSM included performance of subsequent laparoscopic cholecystectomy. Evaluation of minimum performance standards revealed up to a fivefold increased mortality for providers who performed less than 5 ERCP's/year, irrespective of specialty background.
CONCLUSIONS: Gastroenterologists demonstrate favorable gross outcomes compared to surgeons performing ERCP. Differences may correlate in part with more frequent subsequent surgical management of comorbid conditions by surgical providers. Lower volume providers achieve inferior outcomes regardless of specialty background. Analyses of this type may help inform discussions on optimal training and proficiency paradigms, including maintenance of proficiency, for therapeutic endoscopic procedures.

Entities:  

Keywords:  Clinical outcomes; ERCP; Endoscopic retrograde cholangiopancreatography; Endoscopic training; National inpatient sample

Mesh:

Year:  2016        PMID: 27815746     DOI: 10.1007/s00464-016-5312-0

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  16 in total

1.  Do Surgeons and Gastroenterologists Describe Endoscopic Retrograde Cholangiopancreatography Differently? A Qualitative Study.

Authors:  Margaret L Boehler; Nicole Roberts; Hilary Sanfey; John Mellinger
Journal:  J Surg Educ       Date:  2015-09-02       Impact factor: 2.891

Review 2.  Endoscopic retrograde cholangiopancreatography (ERCP): core curriculum.

Authors:  Jennifer Jorgensen; Nisa Kubiliun; Joanna K Law; Mohammad A Al-Haddad; Juliane Bingener-Casey; Jennifer A Christie; Raquel E Davila; Richard S Kwon; Keith L Obstein; Waqar A Qureshi; Robert E Sedlack; Mihir S Wagh; Daniel Zanchetti; Walter J Coyle; Jonathan Cohen
Journal:  Gastrointest Endosc       Date:  2015-12-18       Impact factor: 9.427

3.  Third-tier fellowship training: advantages and program selection.

Authors:  Michael L Kochman
Journal:  Gastrointest Endosc       Date:  2005-03       Impact factor: 9.427

4.  Variation in learning curves and competence for ERCP among advanced endoscopy trainees by using cumulative sum analysis.

Authors:  Sachin Wani; Matthew Hall; Andrew Y Wang; Christopher J DiMaio; V Raman Muthusamy; Rajesh N Keswani; Brian C Brauer; Jeffrey J Easler; Roy D Yen; Ihab El Hajj; Norio Fukami; Kourosh F Ghassemi; Susana Gonzalez; Lindsay Hosford; Thomas G Hollander; Robert Wilson; Vladimir M Kushnir; Jawad Ahmad; Faris Murad; Anoop Prabhu; Rabindra R Watson; Daniel S Strand; Stuart K Amateau; Augustin Attwell; Raj J Shah; Dayna Early; Steven A Edmundowicz; Daniel Mullady
Journal:  Gastrointest Endosc       Date:  2015-10-26       Impact factor: 9.427

5.  ASGE's assessment of competency in endoscopy evaluation tools for colonoscopy and EGD.

Authors:  Gerald M Fried; Jeffrey M Marks; John D Mellinger; Thadeus L Trus; Melina C Vassiliou; Brian J Dunkin
Journal:  Gastrointest Endosc       Date:  2014-08       Impact factor: 9.427

6.  Endoscopic cannulation of the ampulla of vater: a preliminary report.

Authors:  W S McCune; P E Shorb; H Moscovitz
Journal:  Ann Surg       Date:  1968-05       Impact factor: 12.969

Review 7.  Endoscopic retrograde cholangiopancreatography-related adverse events: general overview.

Authors:  Tarun Rustagi; Priya A Jamidar
Journal:  Gastrointest Endosc Clin N Am       Date:  2015-01

Review 8.  ERCP as an outpatient treatment: a review.

Authors:  Suzanne M Jeurnink; Jan Werner Poley; Ewout W Steyerberg; Ernst J Kuipers; Peter D Siersema
Journal:  Gastrointest Endosc       Date:  2008-03-04       Impact factor: 9.427

9.  Lower provider volume is associated with higher failure rates for endoscopic retrograde cholangiopancreatography.

Authors:  Gregory A Coté; Timothy D Imler; Huiping Xu; Evgenia Teal; Dustin D French; Thomas F Imperiale; Marc B Rosenman; Jeffery Wilson; Siu L Hui; Stuart Sherman
Journal:  Med Care       Date:  2013-12       Impact factor: 2.983

10.  Training surgeons in endoscopic retrograde cholangiopancreatography.

Authors:  G C Vitale; C M Zavaleta; D S Vitale; J C Binford; T C Tran; G M Larson
Journal:  Surg Endosc       Date:  2005-12-07       Impact factor: 3.453

View more
  1 in total

1.  Surgeon-performed endoscopic retrograde cholangiopancreatography. Outcomes of 2392 procedures at two tertiary care centers.

Authors:  Mazen R Al-Mansour; Eleanor C Fung; Edward L Jones; Nichole E Zayan; Timothy D Wetzel; Sara E Martin Del Campo; Anahita D Jalilvand; Andrew J Suzo; Rebecca R Dettorre; James K Fullerton; Michael P Meara; John D Mellinger; Vimal K Narula; Jeffrey W Hazey
Journal:  Surg Endosc       Date:  2017-12-22       Impact factor: 4.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.